[1] Wilkins MR, Sanchez JC, Gooley AA, et al. Progress with proteome projects:why all proteins expressed by a genome should be identified and how to do it[J]. Biotechnol Genet Eng Rev, 1995, 13:19-50. [2] Jayaseelan S, Tenenbaum SA. Neurodevelopmental disorders:Signalling pathways of fragile X syndrome[J]. Nature, 2012, 492:359-360. [3] Guerrero C, Tagwerker C, Kaiser P, Huang L. An integrated mass spectrometry-based proteomics approach:QTAX to decipher the 26 S proteasome interacting network[J]. Mol Cell Proteomics, 2006, 5:366-378. [4] Gruhler A, Olsen JV, Mohammed S, et al. Quantitative phosphorpro-teomics applied to the yeast pheromone signaling pathway[J]. Mol Cell Proteomics, 2005, 4:310-327. [5] Haupt A, Joberty G, Bantscheff M, et al. Hsp90 inhibition differenti-ally destabilises MAP kinase and TGF-beta signalling components in cancer cells revealed by kinase-targeted chemoproteomics[J]. BMC Cancer, 2012, 12:38. [6] Moulick K, Ahn JH, Zong H, et al. Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90[J]. Nat Chem Biol, 2011, 7:818-826. [7] Witt SN. Molecular chaperones, alpha-synuclein, and neurodegene-ration[J]. Mol Neurobiol, 2013, 47:552-560. [8] Kato Y, Kajiwara C, Ishige I, et al. HSP70 and HSP90 differentially regulate translocation of extracellular antigen to the cytosol for cross-presentation[J]. Autoimmune Dis, 2012:745962. [9] Simet SM, Pavlik JA, Sisson JH. Proteomic analysis of bovine axonemes exposed to acute alcohol:role of endothelial nitric oxide synthase and heat shock protein 90 in cilia stimulation[J]. Alcohol Clin Exp Res, 2013, 37(4):609-615. [10] Morgan ED, Eunice HL, Elizabeth AS, et al. Operational plasticity enables Hsp104 to disaggregate diverse amyloid and nonamyloid clients[J]. Cell, 2012, 151:778-793. [11] Vert G, Chory J. Crosstalk in cellular signaling:background noise or the real thing?[J]. Dev Cell, 2011, 6:985-991. [12] Wang Y, Ding QQ, Yen CJ, et al. The crosstalk of mTOR/S6K1 and Hedgehog pathways[J]. Cancer Cell, 2011, 21:374-387. [13] Tumaneng K, Schlegelmilch K, Russell RC, et al. YAP mediates crosstalk between the Hippo and PI(3)K-TOR pathways by suppressing PTEN via miR-29[J]. Nature Cell Biology, 2012, 14:1322-1329. [14] Mendoza MC, Er EE, Blenis J. The Ras-ERK and PI3K-mTOR pathways:cross-talk and compensation[J]. Trends Biochem Sci, 2011, 6:320-328. [15] Maniati E, Bossard M, Cook N, et al. Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice[J]. J Clin Invest, 2011, 121:4685-4699. [16] Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-κB signaling pathways[J]. Nature Immunology, 2011, 12:695-708. [17] Singh AM, Reynolds D, Cliff T, et al. Signaling network crosstalk in human pluripotent cells:a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation[J]. Cell Stem Cell, 2012, 3:312-326. [18] Hsu JM, Chen CT, Chou CK, et al. Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation[J]. Nature Cell Biology, 2012, 13:174-181. |